BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Baughman RP, Engel PJ, Nathan S. Pulmonary Hypertension in Sarcoidosis. Clin Chest Med 2015;36:703-14. [PMID: 26593143 DOI: 10.1016/j.ccm.2015.08.011] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Aryal S, Nathan SD. Contemporary optimized practice in the management of pulmonary sarcoidosis. Ther Adv Respir Dis 2019;13:1753466619868935. [PMID: 31409257 DOI: 10.1177/1753466619868935] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
2 Tiosano S, Versini M, Dar Antaki L, Spitzer L, Yavne Y, Watad A, Gendelman O, Comaneshter D, Cohen AD, Amital H. The long-term prognostic significance of sarcoidosis-associated pulmonary hypertension – A cohort study. Clinical Immunology 2019;199:57-61. [DOI: 10.1016/j.clim.2018.12.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
3 Mañá J, Rubio-Rivas M, Villalba N, Marcoval J, Iriarte A, Molina-Molina M, Llatjos R, García O, Martínez-Yélamos S, Vicens-Zygmunt V, Gámez C, Pujol R, Corbella X. Multidisciplinary approach and long-term follow-up in a series of 640 consecutive patients with sarcoidosis: Cohort study of a 40-year clinical experience at a tertiary referral center in Barcelona, Spain. Medicine (Baltimore) 2017;96:e7595. [PMID: 28723801 DOI: 10.1097/MD.0000000000007595] [Cited by in Crossref: 42] [Cited by in F6Publishing: 12] [Article Influence: 8.4] [Reference Citation Analysis]
4 Jose A, Delio J, Gwizdala J, Goulart H, Ahari JE. Predictive value of pulmonary function testing in the evaluation of pulmonary hypertension in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2018;35:308-16. [PMID: 32476918 DOI: 10.36141/svdld.v35i4.6855] [Reference Citation Analysis]
5 Baughman RP, Shlobin OA, Wells AU, Alhamad EH, Culver DA, Barney J, Cordova FC, Carmona EM, Scholand MB, Wijsenbeek M, Ganesh S, Birring SS, Kouranos V, O'hare L, Baran JM, Cal JG, Lower EE, Engel PJ, Nathan SD. Clinical features of sarcoidosis associated pulmonary hypertension: Results of a multi-national registry. Respiratory Medicine 2018;139:72-8. [DOI: 10.1016/j.rmed.2018.04.015] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
6 Kirkil G, Lower EE, Baughman RP. Predictors of Mortality in Pulmonary Sarcoidosis. Chest 2018;153:105-13. [PMID: 28728933 DOI: 10.1016/j.chest.2017.07.008] [Cited by in Crossref: 64] [Cited by in F6Publishing: 51] [Article Influence: 12.8] [Reference Citation Analysis]
7 Llabres M, Brito-Zerón P, Ramos-Casals M, Sellares J. Synthetic pharmacotherapy for pulmonary sarcoidosis. Expert Opin Pharmacother 2019;20:1397-404. [PMID: 31090462 DOI: 10.1080/14656566.2019.1615054] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
8 Bonham CA, Strek ME, Patterson KC. From granuloma to fibrosis: sarcoidosis associated pulmonary fibrosis. Curr Opin Pulm Med 2016;22:484-91. [PMID: 27379967 DOI: 10.1097/MCP.0000000000000301] [Cited by in Crossref: 37] [Cited by in F6Publishing: 25] [Article Influence: 7.4] [Reference Citation Analysis]
9 Culver DA, Judson MA. New advances in the management of pulmonary sarcoidosis. BMJ 2019;367:l5553. [PMID: 31641045 DOI: 10.1136/bmj.l5553] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
10 Bandyopadhyay D, Humbert M. An update on sarcoidosis-associated pulmonary hypertension. Curr Opin Pulm Med 2020;26:582-90. [PMID: 32740377 DOI: 10.1097/MCP.0000000000000701] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Strookappe B, Saketkoo LA, Elfferich M, Holland A, De Vries J, Knevel T, Drent M. Physical activity and training in sarcoidosis: review and experience-based recommendations. Expert Rev Respir Med 2016;10:1057-68. [PMID: 27552344 DOI: 10.1080/17476348.2016.1227244] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
12 Le Pavec J, Valeyre D, Gazengel P, Holm AM, Schultz HH, Perch M, Le Borgne A, Reynaud-gaubert M, Knoop C, Godinas L, Hirschi S, Bunel V, Laporta R, Harari S, Blanchard E, Magnusson JM, Tissot A, Mornex J, Picard C, Savale L, Bernaudin J, Brillet P, Nunes H, Humbert M, Fadel E, Gottlieb J. Lung transplantation for sarcoidosis: outcome and prognostic factors. Eur Respir J 2021;58:2003358. [DOI: 10.1183/13993003.03358-2020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Judson MA. Developing better drugs for pulmonary sarcoidosis: determining indications for treatment and endpoints to assess therapy based on patient and clinician concerns. F1000Res 2019;8:F1000 Faculty Rev-2149. [PMID: 31942239 DOI: 10.12688/f1000research.20696.1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
14 Saketkoo LA, Russell AM, Jensen K, Mandizha J, Tavee J, Newton J, Rivera F, Howie M, Reese R, Goodman M, Hart P, Strookappe B, De Vries J, Rosenbach M, Scholand MB, Lammi MR, Elfferich M, Lower E, Baughman RP, Sweiss N, Judson MA, Drent M. Health-Related Quality of Life (HRQoL) in Sarcoidosis: Diagnosis, Management, and Health Outcomes. Diagnostics (Basel) 2021;11:1089. [PMID: 34203584 DOI: 10.3390/diagnostics11061089] [Reference Citation Analysis]
15 Smedema JP, van Geuns RJ, Ainslie G, Ector J, Heidbuchel H, Crijns HJGM. Right ventricular involvement in cardiac sarcoidosis demonstrated with cardiac magnetic resonance. ESC Heart Fail 2017;4:535-44. [PMID: 29154434 DOI: 10.1002/ehf2.12166] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
16 Sauer WH, Stern BJ, Baughman RP, Culver DA, Royal W. High-Risk Sarcoidosis. Current Concepts and Research Imperatives. Ann Am Thorac Soc 2017;14:S437-44. [PMID: 29073361 DOI: 10.1513/AnnalsATS.201707-566OT] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 5.5] [Reference Citation Analysis]
17 Gupta R, Baughman RP, Nathan SD, Wells AU, Kouranos V, Alhamad EH, Culver DA, Barney J, Carmona EM, Cordova FC, Huitema M, Scholand MB, Wijsenbeek M, Ganesh S, Birring SS, Price LC, Wort SJ, Shlobin OA. The six-minute walk test in sarcoidosis associated pulmonary hypertension: Results from an international registry. Respiratory Medicine 2022;196:106801. [DOI: 10.1016/j.rmed.2022.106801] [Reference Citation Analysis]